.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Moodys
McKinsey
Johnson and Johnson
Cipla
Harvard Business School
AstraZeneca
QuintilesIMS
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

BETIMOL Drug Profile

« Back to Dashboard

What is the patent landscape for Betimol, and what generic Betimol alternatives are available?

Betimol is a drug marketed by Oak Pharms Inc and is included in one NDA.

The generic ingredient in BETIMOL is timolol. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the timolol profile page.

Summary for Tradename: BETIMOL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list23
Patent Applications: see list7,622
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BETIMOL at DailyMed

Pharmacology for Tradename: BETIMOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-001Mar 31, 1995ATRXYesYes► Subscribe► Subscribe► Subscribe
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-002Mar 31, 1995ATRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BETIMOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-001Mar 31, 1995► Subscribe► Subscribe
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-002Mar 31, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
UBS
Colorcon
Covington
Deloitte
Moodys
Boehringer Ingelheim
Queensland Health
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot